Aeton Therapeutics Inc.

Sarasota, FL

UEI
MC2DMP4NVUC7
CAGE
81S25
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
4992 Oarsman Ct, Sarasota, FL 34243, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Aeton Therapeutics Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Acetylated TAU immunotherapy for alzheimer's disease - abstract alzheimer's disease (ad) is one of the most common in… Grant · R41AG085770 National Institute on Aging $999,822
Optimizing virtual hits of human cgas inhibitors to treat neurodegeneration - abstract aeton therapeutics is… Grant · R43AG080954 National Institute on Aging $499,540

Quick answers

What is Aeton Therapeutics Inc.'s UEI?

Aeton Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is MC2DMP4NVUC7.

What is Aeton Therapeutics Inc.'s CAGE code?

Aeton Therapeutics Inc.'s CAGE code is 81S25.

What is Aeton Therapeutics Inc.'s primary NAICS code?

Aeton Therapeutics Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Aeton Therapeutics Inc. located?

Aeton Therapeutics Inc.'s physical address in SAM.gov is 4992 Oarsman Ct, Sarasota, FL 34243, USA.

Is Aeton Therapeutics Inc. registered in SAM.gov?

Yes. Aeton Therapeutics Inc.'s SAM.gov registration is active through December 12, 2026.

What is Aeton Therapeutics Inc.'s most recent federal award?

Aeton Therapeutics Inc.'s most recent federal grant award is Acetylated TAU immunotherapy for alzheimer's disease - abstract alzheimer's disease (ad) is one of the most common in… (R41AG085770), from National Institute on Aging, on September 15, 2024.

On GovTribe

See Aeton Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login